CVS Health Corporation
CVS Health Corporation (CVS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CVS · as of Sep 30, 2025
Ownership Breakdown
1,922
Institutional Holders
▲ 67 vs Q2
$82.38B
Total Inst. Value
▲ $6.85B vs Q2
1.28B
Shares Outstanding
freeFloat 99.79%
1.09B
13F Shares Held
▼ 5.74M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CVS largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. retail-drug stores and proprietary stores | 119.84M | 9.47% | 9.47% | $9.03T | Nov 12, 2025 | ▼ 2.85M |
VANGUARD GROUP INC retail-drug stores and proprietary stores | 118.89M | 9.39% | 9.39% | $8.96T | Nov 7, 2025 | ▼ 1.51M |
DODGE & COX retail-drug stores and proprietary stores | 73.18M | 5.78% | 5.78% | $5.52T | Nov 13, 2025 | ▼ 112.2K |
CAPITAL WORLD INVESTORS retail-drug stores and proprietary stores | 68.38M | 5.40% | 5.40% | $5.16T | Nov 13, 2025 | ▲ 1.42M |
STATE STREET CORP retail-drug stores and proprietary stores | 58.94M | 4.66% | 4.66% | $4.44T | Nov 14, 2025 | ▲ 149.7K |
FMR LLC retail-drug stores and proprietary stores | 43.34M | 3.42% | 3.42% | $3.27T | Nov 13, 2025 | ▼ 2.27M |
JPMORGAN CHASE & CO retail-drug stores and proprietary stores | 35.28M | 2.79% | 2.79% | $2.66T | Nov 26, 2025 | ▲ 8.40M |
GEODE CAPITAL MANAGEMENT, LLC retail-drug stores and proprietary stores | 28.99M | 2.29% | 2.29% | $2.18T | Nov 12, 2025 | ▲ 352.5K |
CAPITAL INTERNATIONAL INVESTORS retail-drug stores and proprietary stores | 26.69M | 2.11% | 2.11% | $2.01T | Nov 13, 2025 | ▲ 302.5K |
INVESCO LTD. retail-drug stores and proprietary stores | 24.29M | 1.92% | 1.92% | $1.83T | Nov 13, 2025 | ▲ 760.6K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
30
Increased
+39.86M shares0
New Positions
first time holders19
Decreased
−20.05M shares0
Sold Out
fully exitedNet shares change (top 50)
+19.81M
+39.86M / −20.05M
Net new holders
+11
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CVS insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
12
Buy transactions
20
Sell transactions
0.60
Buy/Sell ratio
$4M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Newman Brian EVP, Chief Financial Officer | May 31, 2026 | Tax Withhold | 2,478 | $90.98 | $225.4K | 3.0K | Form 4 ↗ |
Compton-Phillips Amy EVP, Chief Medical Officer | May 31, 2026 | Tax Withhold | 7,618 | $90.98 | $693.1K | 9.6K | Form 4 ↗ |
AGUIRRE FERNANDO director | May 20, 2026 | D-Return | 30,437 | $93.78 | $2.85M | 12.1K | Form 4 ↗ |
AGUIRRE FERNANDO director | May 21, 2026 | D-Return | 1,563 | $93.50 | $146.1K | 10.5K | Form 4 ↗ |
ROBBINS LARRY director | May 19, 2026 | Sale | 1,983,387 | $94.45 | $187.33M | 6.21M | Form 4 ↗ |
ROBBINS LARRY director | May 19, 2026 | Sale | 151 | $95.18 | $14.4K | 6.21M | Form 4 ↗ |
ROBBINS LARRY director | May 20, 2026 | Sale | 797,628 | $93.48 | $74.56M | 5.42M | Form 4 ↗ |
ROBBINS LARRY director | May 20, 2026 | Sale | 152,691 | $94.81 | $14.48M | 5.26M | Form 4 ↗ |
ROBBINS LARRY director | May 20, 2026 | Sale | 66,881 | $95.67 | $6.40M | 5.20M | Form 4 ↗ |
ROBBINS LARRY director | May 20, 2026 | Sale | 800 | $96.28 | $77.0K | 5.20M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
CVS Health Corporation (CVS) is primarily owned by institutional investors, who hold approximately 85.6% of total shares outstanding. Company insiders own approximately 0.21%, while retail and public investors account for the remaining 14.15%.
The largest institutional shareholder of CVS Health Corporation is BLACKROCK, INC., holding approximately 119.84 million shares — equal to 9.47% of outstanding shares — as of September 30, 2025.
A total of 1,922 institutional investors currently hold CVS stock, with a combined institutional value of approximately $82.38 billion as of the most recent 13F filing period.
Frequently asked questions
CVS ownershipCVS Health Corporation (CVS) is primarily owned by institutional investors, who hold approximately 85.6% of shares. The largest shareholder is BLACKROCK, INC. with a 9.47% stake. Company insiders hold 0.21%. Data sourced from SEC Form 13F as of September 30, 2025.